“I am determined to keep my kidney for tomorrow.”
*JELMYTO is given through a procedure that does not require removal of the kidney.
Proven to help eliminate tumors in low-grade UTUC
JELMYTO was tested in a clinical study called the OLYMPUS Study. Patients who took part in the study had low-grade UTUC. Some of these patients had very hard-to-reach tumors that could not be removed with endoscopic management. The findings from OLYMPUS showed that:
58% of patients had their tumors disappear after treatment with JELMYTO†
†Results achieved when JELMYTO was given once a week for 6 weeks.
At 1 year, a majority of the patients who had their tumors disappear were still tumor free
Surgery isn't the only way to fight low-grade UTUC. Ask your doctor if JELMYTO is right for you
